Antibiotic residues in animal-derived food = Les résidus d'antibiotiques dans les produits alimentaires d'origine animaleLIVINGSTON, R. C.Journal - Association of official analytical chemists. 1985, Vol 68, Num 5, pp 966-967, issn 0004-5756Conference Paper

Irradiation of fats = L'irradiation des corps grasJournal of the American Oil Chemists' Society. 1984, Vol 61, Num 5, issn 0003-021X, 827Article

The FDA surveillance index for pesticides : establishing food monitoring priorities based on potential health risk = Les indices de contrôle de la FDA pour les pesticides : établissement de priorités de contrôle des produits alimentaires, basées sur les risques potentiels pour la santéREED, D. V.Journal - Association of official analytical chemists. 1985, Vol 68, Num 1, pp 122-124, issn 0004-5756Article

Risk analysis and the interface of science, law, and policy = Analyse des risques d'intoxication et points communs de la science, de la législation et de la politiqueMIDDLEKAUFF, R. D.Food technology (Chicago). 1984, Vol 38, Num 10, pp 97-102, issn 0015-6639Article

Clinical trials in Russia and Eastern Europe: Recruitment and qualityPLATONOV, P.International journal of clinical pharmacology and therapeutics. 2003, Vol 41, Num 7, pp 277-280, issn 0946-1965, 4 p.Article

Pharmacokinetic analysis of the FDA guidance for industry 'Topical dermatologic corticosteroids: in vivo bioequivalence'LEOPOLD, Claudia S.European journal of pharmaceutics and biopharmaceutics. 2003, Vol 56, Num 1, pp 53-58, issn 0939-6411, 6 p.Article

National adverse drug reaction surveillanceFAICH, G. A; DREIS, M; TOMITA, D et al.Archives of internal medicine (1960). 1988, Vol 148, Num 4, pp 785-787, issn 0003-9926Article

On the convergence of a class of estimation of distribution algorithmsQINGFU ZHANG; MÜHLENBEIN, Heinz.IEEE transactions on evolutionary computation. 2004, Vol 8, Num 2, pp 127-136, issn 1089-778X, 10 p.Article

US Governmental Interagency Programs, Opportunities, and CollaborationCHEN, H; PERCHONOK, M.Food science and technology international. 2008, Vol 14, Num 5, pp 447-453, issn 1082-0132, 7 p.Article

The food and drug administration and medroxyprogesterone acetate. What are the issues? = Food and Drug Administration et acétate de médroxyprogestéroneROSENFIELD, A; MAINE, D; ROCHAT, R et al.JAMA, the journal of the American Medical Association. 1983, Vol 249, Num 21, pp 2922-2928, issn 0098-7484Article

The FDA's new procedures for the use of investigational drugs in treatmentYOUNG, FE; NORRIS, J. A; LEVITT, J. A et al.JAMA, the journal of the American Medical Association. 1988, Vol 259, Num 15, pp 2267-2270, issn 0098-7484Article

ADVERSE DRUG REACTIONS: A CONTINUING PROBLEMFELDMANN EG.1983; JOURNAL OF PHARMACEUTICAL SCIENCES; ISSN 0022-3549; USA; DA. 1983; VOL. 72; NO 6; PP. 585Article

FDA PERSPECTIVE ON SODIUM = LES PERSPECTIVES DE LA FDA POUR LE SODIUMSHANK FR; LARSEN L; SCARBROUGH FE et al.1983; FOOD TECHNOLOGY (CHICAGO); ISSN 0015-6639; USA; DA. 1983; VOL. 37; NO 7; PP. 73-77; 4 P.; BIBL. 33 REF.Article

SODIUM LABELING OF MEAT PRODUCTS = LE MARQUAGE DE LA TENEUR EN SODIUM DES PRODUITS CARNESSLEETH RB; KOLARI OE; SVEUM WH et al.1982; PROCEEDINGS OF THE MEAT INDUSTRY RESEARCH CONFERENCE; ISSN 0543-2014; USA; DA. 1982; PP. 13-23; BIBL. 13 REF.; 2 FIG.Article

ROLE OF THE FDA IN CANCER THERAPY RESEARCHYOUNG RSK.1981; SEMIN. ONCOL.; ISSN 0093-7754; USA; DA. 1981; VOL. 8; NO 4; PP. 447-452; BIBL. 11 REF.Article

The WHO, WHY, WHAT, WHEN, WHERE, and HOW of clinical trial registriesMELDRUM, David R; DECHERNEY, Alan H.Fertility and sterility. 2011, Vol 96, Num 1, pp 2-5, issn 0015-0282, 4 p.Article

Role of U.S. military research programs in the development of U.S.-licensed vaccines for naturally occurring infectious diseasesKITCHEN, Lynn W; VAUGHN, David W.Vaccine. 2007, Vol 25, Num 41, pp 7017-7030, issn 0264-410X, 14 p.Article

Challenges in implementing adaptive designs : Comments on the viewpoints expressed by regulatory statisticiansGALLO, Paul; MAURER, Willi.Biometrical journal. 2006, Vol 48, Num 4, pp 591-597, issn 0323-3847, 7 p.Article

FDA's critical path initiative : A perspective on contributions of biostatisticsO'NEILL, R. T.Biometrical journal. 2006, Vol 48, Num 4, pp 559-564, issn 0323-3847, 6 p.Article

FDA's priority-based assessment of food additives. I: Preliminary resultsRULIS, A. M; HATTAN, D. G; MORGENROTH, V. H. III et al.Regulatory toxicology and pharmacology (Print). 1984, Vol 4, Num 1, pp 37-56, issn 0273-2300Article

Stability of 17α-methyltestosterone in fish feedBARRY, Terence P; MARWAH, Ashok; MARWAH, Padma et al.Aquaculture (Amsterdam). 2007, Vol 271, Num 1-4, pp 523-529, issn 0044-8486, 7 p.Article

Enhancing FDA's Post-Market Surveillance of Dietary Supplements: Two Simple Steps to Build CapacityLOBB, Ano.Journal of dietary supplements. 2009, Vol 6, Num 3, pp 204-210, issn 1939-0211, 7 p.Article

Food Chemistry and U.S. Food RegulationsARMSTRONG, David J.Journal of agricultural and food chemistry (Print). 2009, Vol 57, Num 18, pp 8180-8186, issn 0021-8561, 7 p.Article

Approvable letters in the FDA new drug approval processRICHARD, B. W; ULCICKAS, M; LASAGNA, L et al.Journal of clinical pharmacology. 1989, Vol 29, Num 8, pp 680-684, issn 0091-2700Article

How experimental drugs are tested in humansFLIEGER, K.The Pediatric infectious disease journal. 1989, Vol 8, Num 3, pp 160-162, issn 0891-3668Article